Tag Archives | H Walkowiak

Leadership, Management, and Governance Evidence Compendium: Medical Products, Vaccines, and Technologies

This brief on “Medical Products, Vaccines, and Technologies” is one of the chapters of the Leadership, Management, and Governance Evidence Compendium. The USAID-funded Leadership, Management, and Governance (LMG) Project collaborated with the USAID-funded SIAPS program to develop this chapter. The compendium contributes to the evidence base and advocates for continued investment in Leadership, Management, and Governance (L+M+G) activities by examining and documenting the evidence that exists regarding L+M+G’s role in strengthening health system performance in low and middle-income countries. The compendium’s five chapters draw on existing evidence documented in peer-reviewed and grey literature to describe the mechanisms that illustrates L+M+G’s role in the health system and the mechanisms through which L+M+G influences health system functioning.

Read full story · Comments are closed

Strengthening Governance in Pharmaceutical Systems: A Compendium of Country Case Studies

SIAPS and its predecessor programs have assisted numerous countries in strengthening governance to promote robust decision making, enhance accountability, reduce opportunities for corruption, and improve efficiencies to enable better access to and use of quality-assured medicines. This compendium draws on these experiences and provides a collection of examples of strategies and approaches for strengthening governance in pharmaceutical systems. The compendium highlights accumulated insights into factors that may have enabled or constrained the success of governance improvement initiatives. The intention is to systematically bolster knowledge, in alignment with USAID’s collaborating, learning, and adapting approach, so that stakeholders may examine the applicability of lessons learned and apply them in different settings to maximize resources and attain better development results. The compendium begins by defining governance, then explains its importance in pharmaceutical systems and introduces the framework SIAPS has used to guide its governance strengthening activities. It presents eight case studies on SIAPS’ work in enhancing governance in pharmaceutical systems, summarizes challenges commonly encountered and lessons learned, and closes with some reflections on the usefulness of SIAPS’ governance-strengthening framework.

Read full story · Comments are closed

Identifying Indicators for Tracking Pharmaceutical Expenditure in Low- and Middle-Income Countries

SIAPS endeavored to help low- and middle-income countries track Pharmaceutical expenditures (PE) systematically to inform decisions related to the mobilization and allocation of domestic resources and to formulate necessary pharmaceutical finance policies as a key strategy for achieving UHC. Working with its partner, Results for Development (R4D), in 2014, SIAPS reviewed existing approaches that track health and/or PEs. One of the key recommendations from that review was to explore the feasibility of adopting the System of Health Accounts (SHA) methodology to capture PEs. This paper presents the SHA/NHA methodology as a potential platform for capturing PEs and discusses some of the challenges encountered in collecting such expenditure data. It identifies key policy questions that underpin the need for LMICs to comprehensively monitor PEs and discusses a set of proposed indicators they would need to formulate and monitor effective financing policies, particularly toward achieving UHC. It also provides information that enables LMICs and their development partners to realize the challenges in applying the SHA methodology to PE tracking and/or to data collection so that they can take them into consideration during the next phase of piloting these indicators.

Read full story · Comments are closed

What Gets Defined, Gets Measured: A Definition and Framework for Pharmaceutical Systems Strengthening

A presentation by Helena Walkowiak, Principal Technical Advisor for SIAPS, on December 6 2017.

Read full story · Comments are closed

Defining pharmaceutical systems strengthening: concepts to enable measurement

Hafner T, Walkowiak H, Lee D, Aboagye-Nyame F. Defining pharmaceutical systems strengthening: Concepts to enable measurement. Health Policy and Planning Advance Access. 2016; 1-13.

Read the full article


Read full story · Comments are closed

Guide for Malaria Commodities Logistic Management System

Many developing countries are beneficiaries of donations for implementing their malaria programs. Global initiatives and donors, including USAID/PMI; Global Fund to Fight AIDS, Tuberculosis and Malaria; Roll Back Malaria (RBM); and the Bill & Melinda Gates Foundation, expect that the resources they provide reach the affected population and are managed prudently and that reports are submitted regularly. The success of the PMI in reducing malaria deaths by half in 15 target countries in Africa by reaching 85% of the most vulnerable groups depends on the continuous availability of malaria medicines and related commodities. A comprehensive and integrated Logistics Managment System (LMS) for malaria commodities and other essential medicines is necessary to ensure better access and improve quantification, procurement, and distribution.

This guide is intended to assist managers, planners, technical advisors, and health care workers to improve LMS skills for their malaria programs at district, health center (HC), dispensary, and community levels. This document complements existing materials produced by the Strengthening Pharmaceutical Systems Program, such as Quantimed, the Manual for Quantification of Malaria Commodities, and other US Government-funded projects, such as USAID | DELIVER, in applying logistics management approaches that enhance LMS.

Read full story · Comments are closed